Tirzepatide
Dual GLP-1 + GIP agonist. In head-to-head studies, more weight loss on average than GLP-1 alone.
How it works
Tirzepatide activates two gut-hormone receptors instead of one — GLP-1 (the same target semaglutide hits) and GIP. The added GIP activity appears to amplify appetite suppression and metabolic effect, which is why head-to-head trials consistently show larger average weight loss with tirzepatide.
Who it's for
Adults carrying significant excess weight, especially those who've already tried a GLP-1-only medication and found the results real but incomplete. Patients managing type 2 diabetes often do well here too — tirzepatide carries strong glycemic-control data alongside its weight-loss effect.
Choose Your Dose
LIGHT. STANDARD. STRONG.
Pick the strength that matches your protocol. Each option takes you straight to that exact product's secure checkout.
A gentler starting point — well suited if you're new to GLP-1/GIP therapy.
Continue to Checkout StandardOur most commonly prescribed strength for ongoing maintenance dosing.
Continue to Checkout StrongFor patients titrating toward a higher maintenance dose under physician guidance.
Continue to CheckoutA licensed physician reviews and confirms your protocol before anything ships.
Your Timeline
WHAT TO EXPECT
Weeks 1–4
Starter dose. Modest appetite reduction, with mild GI adjustment as your body acclimates.
Weeks 4–16
Your physician steps the dose up gradually on a clinically-guided schedule, based on how you're tolerating it.
Months 4–12
Most patients land on a maintenance dose here. Meaningful, sustained body-weight loss is typical in this window.
Not appropriate for anyone with a personal or family history of medullary thyroid carcinoma or MEN-2, those who are pregnant or breastfeeding, or with active pancreatitis or severe gallbladder disease. Your intake and physician review screen for all of this before anything is prescribed.
Common Questions